Enkephalin degradating enzymes in pheochromocytoma patients

Oncology Reports

Volumn 10, Issue 1, 2003, Pages 253-258

  Balog, Tihomir ^a   Marotti, Tatjana ^a   Sverko, Visnja ^a   Marotti, Miljenko ^b   Krolo, Ivan ^b   Rocic, Boris ^c   Karapanda, Nikola ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Aminopeptidase; Enkephalinase; Pheochromocytomas; Renal tumor

Indexed keywords

CATECHOLAMINE; ENKEPHALIN; MEMBRANE METALLOENDOPEPTIDASE; METENKEPHALIN; MICROSOMAL AMINOPEPTIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADENOMA; ADRENAL TUMOR; ARTICLE; BLOOD; CASE CONTROL STUDY; DOWN REGULATION; ENZYMOLOGY; HUMAN; LIPID PEROXIDATION; METABOLISM; NEUTROPHIL; PATHOLOGY; PHEOCHROMOCYTOMA; UPREGULATION; URINE;

ADENOMA; ADRENAL GLAND NEOPLASMS; ANTIGENS, CD13; CASE-CONTROL STUDIES; CATECHOLAMINES; DOWN-REGULATION; ENKEPHALIN, METHIONINE; ENKEPHALINS; HUMANS; LIPID PEROXIDATION; NEPRILYSIN; NEUTROPHILS; PHEOCHROMOCYTOMA; THIOBARBITURIC ACID REACTIVE SUBSTANCES; UP-REGULATION;

EID: 1842845542     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.1.253     Document Type: Article

References (36)

1. Funasaka Y, Sato H, Chakraborty AK, Chrousos GP and Ichihashi M: Expression of proopiomelanocortin, corticotrophin-releasing hormone (CRH) and CRH receptor in melanoma cells, nervous cells and normal human melanocytes. J Invest Dermatol, Symposium Proceedings 4: 105-109, 1999. (Pubitemid 29489032)
2. Nye EJ, Hockings GI, Grice JE, Strakosch CR, Torpy DJ and Jackson RV: The use of naloxone for investigating disorders of the hypothalamic-pituitary- adrenal axis. Endocrinologist 9: 161-182, 1999. (Pubitemid 29256948)
3. Chretien M, Benjannet S, Gossard F, Gianoulakis C, Crine P and Lis M: From beta-lipotropin to beta-endomorphin and proopiomelanocortin. Can J Biochem 57: 1111-1121, 1979.
4. Simon EJ and Hiller JM: Opioid peptides and opioid receptors. In: Basic Neurochemistry: Molecular, Cellular and Medical Aspects. Siegel GJ (ed). Raven Press Ltd., New York, pp323-328, 1994.
5. Yanase T, Nawata H, Haji M, Kato K and Ibayashi H: Proenkephalin A-derived opioid peptides and mRNA of proenkephalin A in human pheochromocytomas. Mol Cell Endocrinol 51: 237-241, 1987. (Pubitemid 17077431)
6. Haberstock H, Marotti T and Banfic H: Neutrophil signal transduction in Met-enkephalin modulated superoxide anion release. Neuropeptides 30: 193-201, 1996. (Pubitemid 26191214)
7. Plotnikoff NP, Faith RE, Murgo AJ, Herberman RB and Good RA: Short analytical review: methionine enkephalin: a new cytokine - human studies. Clin Immunol Immunopathol 82: 93-101, 1997. (Pubitemid 27072888)
8. Balog T, Marotti T, Abramic M, Beusan-Svoboda I and Hrsak I: The role of aminopeptidase N in Met-enkephalin modulated superoxide anion release. Immunopharmacology 4: 11-20, 1999. (Pubitemid 29044106)
9. Balog T, Marotti T, Abramic M, Beusan-Svoboda I, Sobocanec S and Hrsak I: Neutrophil neutral endopeptidase variation and its regulation by opioid peptides. Int Immunopharmacol 1: 569-579, 2001. (Pubitemid 32197554)
10. Marini M, Roscetti G, Bongiorno L, Urbani A and Roda GL: Hydrolysis and protection from hydrolysis of enkephalin in human plasma. Neurochem Res 15: 61-67, 1990. (Pubitemid 20108411)
11. Shipp MA and Look AT: Hematopoietic dufferentiation antigens that are membrane-associated enzymes: cutting is the key. Blood 82: 1052-1070, 1993. (Pubitemid 23253976)
12. Ansorge S, Schon E and Kunz D: Membrane bound peptidases of lymphocytes: functional implications. Biomed Biochim Acta 50: 799-807, 1991.
13. Amoscato AA, Sramkoski RM, Babcock GF and Alexander JW: Neutral surface aminopeptidase activity of human tumor cell lines. Biochim Biophys Acta 1041: 317-319, 1990.
14. Fujii H, Nakajima M, Saiki I, Yoneda J, Azuma I and Tsuro T: Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin Exp Metastasis 13: 337-344, 1995.
15. Gohring B, Holzhausen HJ, Meye A, Heynemann H, Rebmann U and Langer J: Endopeptidase 24.11 CD10 is down-regulated in renal cell cancer. Int J Mol Med 2: 409-414, 1998.
16. Dragovic T, Deddish PA, Tan FL, Weber G and Erdos EG: Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas. Lab Invest 70: 107-113, 1994. (Pubitemid 24080110)
17. Dianzani MU: Lipid peroxidation and cancer. Crit Rev Oncol Hematol 5: 125-147, 1993.
18. Masotti L, Casali E and Galeotti T: Lipid peroxidation in tumour cells. Free Radic Biol Med 4: 377-386, 1988.
19. Ahmed MI, Fayed ST, Hossein H and Tash FM: Lipid peroxidation and antioxidant status in human cervical carcinoma. Dis Markers 15: 283-291, 1999. (Pubitemid 30050425)
20. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21: 77-89, 1968.
21. + spleen T cells. Arch Biochem Biophys 311: 174-179, 1994.
22. Mari B, Checler F, Ponzio G, Peyron J F, Manie S and Farahifar D: Jurkat T cell express a functional neutral endopeptidase activity (CALLA) involved in T cell activation. EMBO J 11: 3875-3885, 1992.
23. Buege JA and Aust SD: Microsomal lipid peroxidation. Methods Enzymol 30: 303-310, 1978.
24. George SR and Kertesz M: Dopamine receptors regulate Metenkephalin content in pituitary. Brain Res 334: 187-189, 1985. (Pubitemid 15094665)
25. Straus B: Medicinska Biokemija. Stavljenic A, Softie N and Cepelak I (eds). JUMENA, Zagreb, pp640-645, 1988.
26. Kimura T, Ota K, Matsui K, Iitake K, Shoj M and Inoue M: The presence of methionine enkephalin in plasma and urine in normal human subjects and various patients. Endocr J 32: 517-527, 1985. (Pubitemid 16174522)
27. Woolf PD: Endocrinology of shock. Ann Emerg Med 15: 1401-1405, 1986.
28. Manger WM and Gifford RW Jr: Pheochromocytoma: current diagnosis and management. Cleve Clin J Med 60: 365-378, 1993. (Pubitemid 23294833)
29. Turner AJ and Tanazawa K: Mammalian membrane metallopeptidases: NEP, ECE, KELL and PEX. FASEB J 11: 355-364, 1997. (Pubitemid 27193940)
30. Amoscato AA, Spiess RP, Sansoni SB, Herberman RB and Chambers WH: Degradation of enkephalins by rat lymphocyte and purified rat natural killer cell surface aminopeptidases. Brain Behav Immun 7: 176-187, 1993. (Pubitemid 23222551)
31. Gauchez AS, Riondel J, Jacort M, Calop J and Favier A: Antioxidant status and lipid peroxidation in athymic mice xenografted with two types of human tumors. Biol Trace Elem Res 47: 103-109, 1995.
32. Giraud P, Castanas E, Oliver C, Eiden L, Boudouresque F and Jaquet P: Demonstration of enkephalines in pheochromocytoma. Arch Mal Coeur Vaiss 75: 143-146, 1982.
33. Baldi E, De Feo ML, Geppetti P, Carla V, Maggi M and Pupilli C: Measurement of cateholamines, met-enkephalin, somatostatin and substance P-like immunoreactivities in 12 human pheochromocytomas. J Endocrinol Invest 11: 133-138, 1988. (Pubitemid 18070533)
34. Yoshimasa T, Nakao K, Li S, Ikeda Y, Suda M and Sakamoto M: Plasma methionine-enkephalin and leucine-enkephalin in normal subject and patients with pheochromocytoma. J Clin Endocrinol Metab 57: 706-712, 1983. (Pubitemid 13013525)
35. Parmer RJ, Mosley C and O'Connor DT: Enkephalins in pheochromocytomas: studies in rat model. Clin Exp Hypertens 7: 483-512, 1985. (Pubitemid 15073395)
36. Bostwick DG, Null WE, Holmes D, Weber E, Barchas JD and Bensch KG: Expression of opioid peptides in tumors. N Engl J Med 317: 1439-1443, 1987. (Pubitemid 17158166)